For example, IMPA1 and/or IMPA2 are either up- or down-regulated in breast, renal and ovarian cancer (among others, previously reviewed in [63]), and were shown to directly contribute to cancer growth by regulating Akt/mTOR signalling and epithelial‐mesenchymal transition [64–66]. Here, IMPA2 is linked to cancer.